(¿Â¶óÀÎ) 2024 ´ëÇÑÇ÷¾×ÇÐȸ ºÐ±âÁý´ãȸ : 2024-02-22
±³À°ÀÏÀÚ : 2024-02-22
±³À°Àå¼Ò : ¿Â¶óÀÎ
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2024 ´ëÇÑÇ÷¾×ÇÐȸ ºÐ±âÁý´ãȸ
ÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
´ã´çÀÚ : ±èÇýÁø
¿¬¶ôó : 02-516-6581
À̸ÞÀÏ : hematology@kams.or.kr
±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Áø´Ü°Ë»çÀÇÇаú
Âü¼®¿¹»óÀÎ : 120¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 50,000¿ø
ºñ°í ºñȸ¿ø Àü¹®ÀÇ 50,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 02¿ù 22ÀÏ A 17:00~18:00 Myeloproliferative neoplasms ÃÖö¿ø(°í·ÁÀÇ´ë)
±³À°½Ã°£ 02¿ù 22ÀÏ A 18:00~18:30 ddPCR for BCR-ABL1 ±èÇöÁö(¼¿ïÀÇ´ë)
±³À°½Ã°£ 02¿ù 22ÀÏ A 18:30~19:00 Overlooked TK fusion in MPN(Myeloproliferative neoplasms) with eosinophilia ¹Ú½Â¹Î(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 02¿ù 22ÀÏ A 19:00~19:30 2-line therapy with fedratinib / Pregnancy in MPN(Myeloproliferative neoplasms) ³²È£¿µ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 02¿ù 22ÀÏ A 19:30~20:00 Lymphoma ±è»ó¾Æ(¼¿ïÀÇ´ë)